European Commission approves Roche's Tecentriq SC, the EU's

Subcutaneous injection offers the potential for a faster, more convenient alternative to intravenous infusion and is preferred by cancer patients, nurses and physicians1-5Tecentriq SC reduces...

Related Keywords

Japan , Switzerland , Spain , United Kingdom , United States , America , Great Britain , Birgit Masjost , Kirti Pandey , Bruno Eschli , Sileia Urech , Enriqueta Felip , Rebekka Schnell , Sabine Borngr , Loren Kalm , Levi Garraway , Simon Goldsborough , Nathalie Altermatt , Karsten Kleine , Head Of Global Product Development , Genentech , European Commission , European Medicines Agency , Roche Group , European Union , Chief Medical Officer , Global Product , Thoracic Cancer Unit , Hebron Hospital , Halozyme Therapeutic Enhanze , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Cancer Res , Markets ,